Impact of Fixed-Duration Oral Targeted Therapies on the Economic Burden of Chronic Lymphocytic Leukemia in Canada.

Lachaine J, Guinan K, Aw A, Banerji V, Fleury I, Owen C.

Open source

DOI
10.3390/curroncol30050339
Published
2023-04-24
Container
Curr Oncol
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/curroncol30050339,
  title = {Impact of Fixed-Duration Oral Targeted Therapies on the Economic Burden of Chronic Lymphocytic Leukemia in Canada.},
  author = {Lachaine J and  Guinan K and  Aw A and  Banerji V and  Fleury I and  Owen C.},
  year = {2023},
  journal = {Curr Oncol},
  doi = {10.3390/curroncol30050339},
  url = {https://doi.org/10.3390/curroncol30050339}
}

RIS

TY  - JOUR
TI  - Impact of Fixed-Duration Oral Targeted Therapies on the Economic Burden of Chronic Lymphocytic Leukemia in Canada.
AU  - Lachaine J
AU  -  Guinan K
AU  -  Aw A
AU  -  Banerji V
AU  -  Fleury I
AU  -  Owen C.
PY  - 2023
JO  - Curr Oncol
DO  - 10.3390/curroncol30050339
UR  - https://doi.org/10.3390/curroncol30050339
ER  - 

APA

J, L., K, G., A, A., V, B., I, F., & C., O. (2023). Impact of Fixed-Duration Oral Targeted Therapies on the Economic Burden of Chronic Lymphocytic Leukemia in Canada.. Curr Oncol. https://doi.org/10.3390/curroncol30050339

Source records